Structure-guided design of a selective BCL-X(L) inhibitor.

@article{Lessene2013StructureguidedDO,
  title={Structure-guided design of a selective BCL-X(L) inhibitor.},
  author={Guillaume Lessene and Peter E. Czabotar and Brad E Sleebs and Kerry Zobel and Kym N. Lowes and Jerry M. Adams and Jonathan B. Baell and Peter M. Colman and Kurt D Deshayes and Wayne J. Fairbrother and John A. Flygare and Paul A Gibbons and Wilhelmus J A Kersten and Sanji Kulasegaram and Rebecca M. Moss and John P. Parisot and Brian J Smith and Ian P. Street and Hong Yang and David C S Huang and Keith G Watson},
  journal={Nature chemical biology},
  year={2013},
  volume={9 6},
  pages={390-7}
}
The prosurvival BCL-2 family protein BCL-X(L) is often overexpressed in solid tumors and renders malignant tumor cells resistant to anticancer therapeutics. Enhancing apoptotic responses by inhibiting BCL-X(L) will most likely have widespread utility in cancer treatment and, instead of inhibiting multiple prosurvival BCL-2 family members, a BCL-X(L)-selective inhibitor would be expected to minimize the toxicity to normal tissues. We describe the use of a high-throughput screen to discover a new… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 7 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 97 extracted citations

Similar Papers

Loading similar papers…